|  Part I | Cutting Edge of Cancer Research
  | 좌장 : 이규완, 이준모 |  | 09:00-09:25 | Aberrant CpG island hypermethylaion in gynecologic tumors
  | 강경훈(서울의대)
  | 25분 |  | 09:25-09:50 | Proteomics in gyn-cancer screening 
  | 김재훈(연세의대)
  | 25분 |  | 09:50-10:15 | Recent progress of cancer vaccine
  | 유상영(원자력의학원)
  | 25분 |  | 10:15-10:30 | 지명토론-강석범(국립암센터), 김재원(서울의대), 안웅식(가톨릭의대)
  | 15분 |  | 10:30-11:00 | 휴식 |   | 30분 |  
  |  | Part II | Cancer Clinical Trials II
  | 좌장 :김경태, 최호선 |  | 11:00-11:20 | Clinical trial evaluation&support system in US
  | 류백렬(원자력의학원)
  | 20분 |  | 11:20-11:40 | Experiences of KCSG (Korean Cancer Study Group)
  | 박영석(성균관의대)
  | 20분 |  | 11:40-12:00 | Experiences of KROG (Korean Radiation Oncology Group)
  | 조관호(국립암센터)
  | 20분 |  | 12:00-12:15 | 지명토론-김원규(고신의대), 김승철(이화의대), 유희석(아주의대)
  | 15분 |  | 12:15-13:20 | 점심 | 65분 |  
  |  |  Part III | Controversies in Management of Gynecologic Cancers II
  | 좌장 :이승호, 남주현  |  
  |  | 13:20-14:00 | Recurrent ovarian cancer is best treated by multiagent chemotherapy
  | Pro 김석모(전남의대) | 40분 |  | Con 김종혁(울산의대) |  | 14:00-14:40 | Neoadjuvant chemotherapy followed by interval debulking in ovarian cancer
  | Pro 김영태(연세의대) | 40분 |  | Con 이재관(고려의대) |  | 14:40-14:50 | 지명토론-이윤순(경북의대), 김병기(성균관의대)
  | 10분 |  | 14:50-15:20 | 휴식 |   | 30분 |   |  | 15:20-16:00 | Adjuvant RT should be standard treatment for early stage endometrial cancer after surgery
  | Pro 조철구(원자력학원) | 40분 |  | Con 허수영(가톨릭의대) |  | 16:00-16:40 | Neoadjuvant chemotherapy followed by radical surgery in stage Ib2 cervical cancer
  | Pro 이종민(가천의대) | 40분 |  | Con 이기현(성균관의대) |  | 16:40-16:50 | 지명토론-김영탁(울산의대) , 박상윤(국립암센터)
  | 10분 |  
  |   |  
  |  
  |